logo

 

MIRA INFORM REPORT

 

 

Report Date :

27.05.2013

 

IDENTIFICATION DETAILS

 

Name :

INCHEM LABORATORIES PRIVATE LIMITED (w.e.f. 12.11.2010)

 

 

Formerly Known As :

SRI SAI ORGANICS PRIVATE LIMITED

 

 

Registered Office :

8-3-214/54/3/B-16, Madhura Nagar, Hyderabad- 500038, Andhra Pradesh

 

 

Country :

India

 

 

Financials (as on) :

31.03.2012

 

 

Date of Incorporation :

05.12.2006

 

 

Com. Reg. No.:

01-051498

 

 

Capital Investment / Paid-up Capital :

Rs. 18.790 millions

 

 

CIN No.:

[Company Identification No.]

U24110AP2006PTC051498

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

HYDS17869F

 

 

PAN No.:

[Permanent Account No.]

AAKCS2948C

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

Manufacturer of Pharmaceuticals.

 

 

No. of Employees :

Not Available

 

 

RATING & COMMENTS

 

MIRA’s Rating :

B (30)

 

RATING

STATUS

PROPOSED CREDIT LINE

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

Small

 

Maximum Credit Limit :

USD 85000

 

 

Status :

Moderate

 

 

Payment Behaviour :

Slow but correct

 

 

Litigation :

Clear

 

 

Comments :

Subject is a company having a moderate track record.

 

Financial position of the company appears below average.

 

However, trade relations are fair. Business is active. Payment terms are recorded as slow but correct.

 

The company can be considered for business dealings with some caution.

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – June 30, 2012

 

Country Name

Previous Rating

(31.03.2012)

Current Rating

(30.06.2012)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2012.

 

 

LOCATIONS

 

Registered Office :

8-3-214/54/3/B-16, Madhura Nagar, Hyderabad- 500038, Andhra Pradesh, India

Tel. No.:

91- 40-23708811

Fax No.:

91- 40-23708822

E-Mail :

finance.inchemlabs@gmail.com

info@srisaiorganics.com

purchase@inchemlabs.com

ed@inchemlabs.com

marketing@inchemlabs.com

info@inchemlabs.com

export@inchemlabs.com

Website :

www.inchemlabs.com

 

 

Factory :

Plot No.52C, IDA Kondapally, Ibrahimpatnam Mandal, Krishna District-521228, Andhra Pradesh, India

 

 

DIRECTORS

 

As on 26.09.2012

 

Name :

Mr. Srinivas Reddy Kasam

Designation :

Managing Director

Address :

A-121, Journalist Colony, Jubilee Hills, Hyderabad-500045, Andhra Pradesh, India

Date of Birth/Age :

11.09.1969

Date of Appointment :

01.04.2008

DIN No.:

00058360

 

 

Name :

Mr. Vinodbabu Madhavaram

Designation :

Whole-Time Director

Address :

9-1-75/1/3, Old Bowenpally, Hasmathpet, Hyderabad-500011, Andhra Pradesh, India

Date of Birth/Age :

14.07.1965

Date of Appointment :

11.12.2006

DIN No.:

01851856

 

 

Name :

Mr. Poduuturi Rajashekar Reddy

Designation :

Director

Address :

F-32, Defence Colony, Sikh Village, Secunderabad, Andhra Pradesh, India

Date of Birth/Age :

16.08.1972

Date of Appointment :

05.12.2006

DIN No.:

01851907

 

 

Name :

Mr. Suresh Avanthi

Designation :

Director

Address :

Plot No 303, Parkview Enclave, Opposite Telephone Exchange, Kphb Kukat Pally, Hyderabad-500072, Andhra Pradesh, India

Date of Birth/Age :

20.06.1971

Date of Appointment :

05.12.2006

DIN No.:

01904055

 

 

KEY EXECUTIVES

 

Name :

Mr. Radhakrishna

Designation :

Accounts Department

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

As on 26.09.2012

 

Names of Shareholders

 

No. of Shares

Podduturi Rajashekar Reddy

 

1208166

Vinodbabu Madhavaram

 

528321

A. Suresh

 

93513

Arvind Bhupatrai Sheth

 

6000

Amit Arvind Sheth

 

8000

Ashish Arvind Sheth

 

8000

Orbit Life Science Private Limited, India

 

27000

Total

 

1879000

 

As on 26.09.2012

 

Equity Share Break up (Percentage of Total Equity)

 

Category

Percentage of Holding

Bodies corporate

1.44

Directors or relatives of Directors

98.56

Total

100.00

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturer of Pharmaceuticals.

 

 

Products :

  • Amisulpride      
  • Balofloxacin
  • Divalproex Sodium
  • Divalproex Sodium (70:30)
  • Levosulpiride
  • Magnesium Valproate
  • Montelukast Sodium
  • Phenytoin Sodium
  • Ractopamine Hydrochloride
  • Sodium Valproate
  • Valproic Acid
  • Zinc Carnocine
  • Moxifloxacin Hydrochloride
  • Rosuvastatin Calcium
  • Zilpaterol Hydrochloride

 

PRODUCTION STATUS AS ON 31.03.2011

 

Particulars

Unit

31.03.2011

Licensed Capacity

TPA

100

 

 

GENERAL INFORMATION

 

No. of Employees :

Not Available

 

 

Bankers :

Canara Bank 3-06-65,Basheerbagh, Beside Skyline Theatre, Hyderabad - 500029, Andhra Pradesh, India

 

 

Facilities :

Secured Loan

31.03.2012

(Rs. in Millions)

31.03.2011

(Rs. in Millions)

Term loan from Canara Bank

1.048

3.021

Cash credit from Canara Bank

18.415

20.555

Packing Credit loan from Canara Bank

3.966

0.658

Total

23.429

24.234

 

Note:

 

Term loans from Canara Bank are secured by first charge on immovable properties both present and future by equitable mortagage by deposit of title deeds of the Company's land wherever situated.

 

Personal guarantees given by Managing Director and Director of the Company.

 

There is no default in repayment of principal loan or interest thereon.

 

Working capital loans from Canara Bank are secured by way of hypothecation of oil stocks, book debts and other current assets both present and future.

 

Personal guarantees given by Managing Director and Director of the Company.

 

There is no default in repayment of principal loan or interest thereon.

 

 

 

Banking Relations :

--

 

 

Auditors :

 

Name :

K. Nagaraju and Associates

Chartered Accountants

Address :

No.1-8-197, Chikkadpally, Hyderabad- 500020, Andhra Pradesh, India

PAN No.:

ABHPK1930B

 

 

CAPITAL STRUCTURE

 

As on 31.03.2012

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

2000000

Equity Shares

Rs.10/- each

Rs. 20.000 Millions

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

1879000

Equity Shares

Rs.10/- each

Rs. 18.790 Millions

 

 

 

 

 


 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2012

31.03.2011

31.03.2010

SHAREHOLDERS FUNDS

 

 

 

1] Share Capital

18.790

1.000

0.100

2] Share Application Money

1.210

0.000

2.782

3] Reserves & Surplus

1.153

0.000

0.000

4] (Accumulated Losses)

0.000

(0.934)

(1.310)

NETWORTH

21.153

0.066

1.572

LOAN FUNDS

 

 

 

1] Secured Loans

23.429

24.234

30.962

2] Unsecured Loans

7.408

5.000

14.798

TOTAL BORROWING

30.837

29.234

45.760

DEFERRED TAX LIABILITIES

0.402

0.000

0.734

 

 

 

 

TOTAL

52.392

29.300

48.066

 

 

 

 

APPLICATION OF FUNDS

 

 

 

 

 

 

 

FIXED ASSETS [Net Block]

29.844

25.999

21.147

Capital work-in-progress

3.565

3.819

0.340

 

 

 

 

INVESTMENT

0.000

0.000

0.000

DEFERRED TAX ASSETS

0.000

0.058

1.221

 

 

 

 

CURRENT ASSETS, LOANS & ADVANCES

 

 

 

 

Inventories

76.623

53.372

31.403

 

Sundry Debtors

13.822

16.981

10.838

 

Cash & Bank Balances

1.859

1.876

1.123

 

Other Current Assets

0.011

0.013

0.000

 

Loans & Advances

12.443

10.316

7.595

Total Current Assets

104.758

82.558

50.959

Less : CURRENT LIABILITIES & PROVISIONS

 

 

 

 

Sundry Creditors

55.643

39.816

24.640

 

Other Current Liabilities

25.581

41.766

0.000

 

Provisions

4.551

1.552

0.966

Total Current Liabilities

85.775

83.134

25.606

Net Current Assets

18.983

(0.576)

25.353

 

 

 

 

MISCELLANEOUS EXPENSES

0.000

0.000

0.005

 

 

 

 

TOTAL

52.392

29.300

48.066

 

 


 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

31.03.2012

31.03.2011

31.03.2010

 

SALES

 

 

 

 

 

Income

155.510

101.309

60.239

 

 

Other Income

NA

NA

0.212

 

 

TOTAL                                     (A)

NA

NA

60.451

 

 

 

 

 

Less

EXPENSES

 

 

 

 

Raw Material Consumed

 

 

49.369

 

 

Salaries, Wages and Benefits to Employees

 

 

7.907

 

 

Other Manufacturing Overheads

 

 

5.572

 

 

Administrative and Selling Expenses

 

 

3.192

 

 

Prior Period Expenses

 

 

0.014

 

 

Increase / (Decrease) in Stock

 

 

(11.365)

 

 

TOTAL                                     (B)

NA

NA

54.689

 

 

 

 

 

 

PROFIT BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION (A-B)     (C)

NA

NA

5.762

 

 

 

 

 

Less

FINANCIAL EXPENSES                                    (D)

NA

NA

3.775

 

 

 

 

 

 

PROFIT  BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D)                                       (E)

NA

NA

1.987

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION                     (F)

NA

NA

1.728

 

 

 

 

 

 

PROFIT BEFORE TAX (E-F)                             (G)           

NA

NA

0.259

 

 

 

 

 

Less

TAX                                                                  (H)

NA

NA

0.128

 

 

 

 

 

 

PROFIT AFTER TAX (G-H)                                (I)

2.087

0.377

0.131

 

 

 

 

 

Add

PREVIOUS YEARS’ BALANCE BROUGHT FORWARD

(0.934)

(1.311)

(1.442)

 

 

 

 

 

 

BALANCE CARRIED TO THE B/S

1.153

(0.934)

(1.311)

 

 

 

 

 

 

EARNINGS IN FOREIGN CURRENCY

57.424

2.151

3.118

 

 

 

 

 

 

Earnings Per Share (Rs.)

1.11

NA

NA

 

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2012

31.03.2011

31.03.2010

PAT / Total Income

(%)

NA

NA

0.22

 

 

 

 

 

Net Profit Margin

(PBT/Sales)

(%)

NA

NA

0.43

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

NA

NA

0.36

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

NA

NA

0.16

 

 

 

 

 

Debt Equity Ratio

(Total Debt/Networth)

 

1.46

442.94

29.11

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

1.22

0.99

1.99

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Sr. No.

Check List by Info Agents

Available in Report (Yes / No)

1]

Year of Establishment

Yes

2]

Locality of the firm

Yes

3]

Constitutions of the firm

Yes

4]

Premises details

No

5]

Type of Business

Yes

6]

Line of Business

Yes

7]

Promoter's background

Yes

8]

No. of employees

No

9]

Name of person contacted

No

10]

Designation of contact person

No

11]

Turnover of firm for last three years

Yes

12]

Profitability for last three years

Yes

13]

Reasons for variation <> 20%

-----

14]

Estimation for coming financial year

No

15]

Capital in the business

Yes

16]

Details of sister concerns

No

17]

Major suppliers

No

18]

Major customers

No

19]

Payments terms

No

20]

Export / Import details (if applicable)

No

21]

Market information

-----

22]

Litigations that the firm / promoter involved in

-----

23]

Banking Details

Yes

24]

Banking facility details

Yes

25]

Conduct of the banking account

-----

26]

Buyer visit details

-----

27]

Financials, if provided

Yes

28]

Incorporation details, if applicable

Yes

29]

Last accounts filed at ROC

Yes

30]

Major Shareholders, if available

Yes

31]

Date of Birth of Proprietor/Partner/Director, if available

Yes

32]

PAN of Proprietor/Partner/Director, if available

No

33]

Voter ID No of Proprietor/Partner/Director, if available

No

34]

External Agency Rating, if available

No

 

 

NOTE

 

The registered office of the company has been shifted from H. No. 8-3-222 / B / 7 / 60 / A, D - 81, Madhura Nagar, Sanjeev Reddy Nagar (Post), Hyderabad-500038, Andhra Pradesh, India  to the present address w.e.f. 01.11.2011

 

 

REVIEW OF OPERATIONS:

 

The company has achieved a total income of Rs. 155.510 millions during the year as against Rs. 101.309 millions during the last year. During the year, the company has earned Net Profit of Rs.2.087 millions as against Net Profit of Rs. 0.377 million during the last year.

 

 

FUTURE PLANS:

 

  • After upgrading our facilities and adding modern and upgraded equipment they could successfully complete the audits of Ranbaxy/ Cipla and also Abbott India Limited.

 

With these audits approval, It’s going to increase the turnover and also profitability for this coming financial years.

 

  • They could successfully commercialize couple of products developed at their new R&D Centre, here at Hyderabad and are looking forward to add new facilities so that we can start production of another two molecules already developed by our R&D team.

 

They have upgraded R&D also and have got all the relevant permissions from the departments concerned to start the kilo labs; which hopefully will be operational by this year end.

 

  • Their exports value will be more than 30% from the total turnover of their company and are targeting to achieve at least 50% of the turnover from exports by the end of 2013.

 

  • It has been decided to add new facilities and also upgrade the existing facilities to meet WHO cGMP/EDQM requirements to meet the ever growing standards of the industry.

 

  • They will be a 30 Cr company by 2012-13 financial year.

 

 

UNSECURED LOAN

 

Particulars

31.03.2012

(Rs. in Millions)

31.03.2011

(Rs. In Millions)

Loan from Directors and NBFC’S

7.408

5.000

Total

 7.408

5.000

 

 

BANKERS CHARGES REPORT AS PER REGISTRY

 

Corporate identity number of the company

U24110AP2006PTC051498

Name of the company

INCHEM LABORATORIES PRIVATE LIMITED

Address of the registered office or of the principal place of  business in India of the company

8-3-214/54/3/B-16, Madhura Nagar, Hyderabad- 500038, Andhra Pradesh, India

E-mail:

This form is for

Modification of charge

Charge identification (ID) number of the charge to be modified

10121540

Type of charge

Immovable property

Book debts

Others (Stocks)

Particular of charge holder

Canara Bank 3-06-65,Basheerbagh, Beside Skyline Theatre, Hyderabad - 500029, Andhra Pradesh, India

E-mail: managercb0878@canarabank.com

Nature of instrument creating charge

Pronote

LEDTD where additional limit is granted on the very security Supplemental common hypothecation agreement

Date of instrument Creating the charge

15.01.2013

Amount secured by the charge

Rs. 76.300 millions

Brief of the principal terms an conditions and extent and operation of the charge

Rate of Interest

OCC/DBD = 15.25% p.a

TL1 and TL2 = 14.75% p.a

TL3 = 14.75% p.a

PC/FDB/FBE = 10.50% p.a

 

Terms of Repayment

same as earlier

 

Margin

not applicable

 

Extent and Operation of the charge

The Charge operates as a security to the extent of Rs.76.300 millions together with all the costs, charges and expenses if any incurred or borne by the bank present and future.

Short particulars of the property or asset(s) charged (including complete address and location of the property)

Entire Fixed Assets of the company excluding vehicles valued Rs. 29.690 millions as per Audited Balance Sheet March – 2012

 

Hypothecation of book debts valued Rs. 90.443 millions and goods received

Date of instrument modifying the charge

09.11.2012

Particulars of the present modification

The previous Term Loan and other facilities which total to Rs.81.300 millions have been modified to Rs.76.300 millions

 

 

FIXED ASSETS

 

  • Land
  • Building
  • Plant and Machinery
  • Lab Equipment
  • Factory Equipment
  • Computers
  • Furniture and Fixtures
  • Vehicles
  • Office Equipment

 

CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                           None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                        None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                        None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 


 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.55.61

UK Pound

1

Rs.83.98

Euro

1

Rs.71.94

 

 

INFORMATION DETAILS

 

Report Prepared by :

MRI

 


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

3

PAID-UP CAPITAL

1~10

4

OPERATING SCALE

1~10

3

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

3

--PROFITABILIRY

1~10

4

--LIQUIDITY

1~10

3

--LEVERAGE

1~10

3

--RESERVES

1~10

4

--CREDIT LINES

1~10

3

--MARGINS

-5~5

--

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

NO

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

DEFAULTER

 

 

--RBI

YES/NO

NO

--EPF

YES/NO

NO

TOTAL

 

30

 

 

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

NB

NEW BUSINESS

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.